■慢性疼痛是导致残疾的主要原因,严重损害个人的日常活动和生活质量。此外,这种情况可能会导致神经心理障碍,从而导致自杀念头,感觉到生活中缺乏意义,和疼痛相关的灾难化。本系统评价旨在全面调查自杀行为(SB)的患病率和相关因素,包括自杀意念(SI)和自杀未遂(SA)或其完整性,在患有慢性疼痛的个体中。
■截至2022年10月4日,搜索了五个电子数据库。仅包括调查慢性疼痛个体中SB患病率的观察性研究。使用加强流行病学观察研究报告(STROBE)声明评估纳入研究的方法学质量。进行了荟萃分析,以量化人群中SB的患病率,并且在STATA/MP16中使用了命令“Metaprop”。此外,研究了解释慢性疼痛与通过回归分析鉴定的SB之间关联的因素.
■本综述共纳入19项研究(N=3,312,343)。SI和SA的合并终生患病率为28.90%(95%置信区间,17.95至41.26%)和10.83%(5.72至17.30%),分别,在包含各种慢性疼痛病症的混合样品中。重要的是,过去2周SI的合并患病率高达25.87%(18.09~34.50%).纳入研究的方法学质量并不理想,缺乏使用经过验证的SB评估工具的研究。该人群中针对SB的潜在保护因素包括疼痛应对和自我效能感,年龄较大,某些种族/族裔群体,和婚姻。
■这项系统评价和荟萃分析证明了慢性疼痛患者中SB的高患病率。具体来说,约1/4的慢性疼痛患者在过去2周内出现SI.然而,该人群中SB的汇总患病率存在相当大的异质性.
UNASSIGNED: Chronic pain is a leading cause of disability, severely impairing an individual\'s daily activity and quality of life. In addition, this condition may contribute to suicidal thoughts by leading to neuropsychological impairments, a perceived lack of meaning in life, and pain-related catastrophizing. This systematic
review aimed to comprehensively investigate the prevalence and associated factors of suicidal behaviors (SBs) including suicidal ideation (SI) and suicide attempt (SA) or its complete, in individuals with chronic pain.
UNASSIGNED: Five electronic databases were searched up to October 4, 2022. Only observational studies investigating the prevalence of SB in individuals with chronic pain were included. The methodological quality of the included studies was assessed using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. A meta-analysis was conducted to quantify the prevalence of SB in the population, and the command \"Metaprop\" was used in STATA/MP 16. In addition, factors explaining the association between chronic pain and SB identified through regression analysis were investigated.
UNASSIGNED: A total of 19 studies were included in this
review (N = 3,312,343). The pooled lifetime prevalence of SI and SA was 28.90% (95% confidence interval, 17.95 to 41.26%) and 10.83% (5.72 to 17.30%), respectively, in a mixed sample comprising various chronic pain conditions. Importantly, the pooled prevalence of past 2-week SI was as high as 25.87% (18.09 to 34.50%). The methodological quality of the included studies was not optimal, and studies using validated SB assessment tools were lacking. Potential protective factors against SB in this population included pain coping and self-efficacy, older age, certain race/ethnicity groups, and marriage.
UNASSIGNED: This systematic
review and meta-analysis demonstrated the high prevalence of SB in individuals with chronic pain. Specifically, around 1 in 4 individuals with chronic pain had SI within the last 2 weeks. However, there was considerable heterogeneity in the pooled prevalence of SB in this population.